Indocyanine green dye during stomach surgery for leftover cancer
Part of Cancer, Digestive system clinical trials.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 75 years old.
- Your diagnosis is remnant stomach cancer (not widespread) based on scans before surgery.
- Pre-op scans show no distant spread and no direct invasion into nearby organs like the pancreas, spleen, or other nearby organs.
- Your general health is fairly good (ECOG performance status 0 or 1) and your anesthesia risk class is 1 to 3 (ASA).
- You are not pregnant or breast-feeding, and you can sign the study consent form.
- You should not have a serious iodine allergy, and you likely have no recent major heart/ lung limits or certain other cancers/ treatments in the last few years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.
This study tests whether using a green dye (called indocyanine green) during keyhole surgery helps doctors find and remove lymph nodes more accurately in stomach cancer. It may help reduce the chance of leaving cancer behind.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.